Belongs to

• Solid Tumor Oncology Division

Types of Work

["2018"]

[[["Journal Articles",2302],["Meeting Abstracts",1890],["Book Sections",73],["Conference Papers",27],["Reviews",27],["Editorials",13],["Correspondences",10],["Guidelines",5],["Books Whole",4],["Research Letters",4],["Miscellaneous",2]]]

[4357]

Popular keywords

• adult
• aged
• article
• controlled study
• human
• humans
• major clinical study
• male
• priority journal
• prostate cancer

Recent Works

1. Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV-201): a multicentre, single-arm, phase 2 trial

   Journal Article

   Yu, E. Y.; Petrylak, D. P.; O'Donnell, P. H.; Lee, J. L.; van der Heijden, M. S.; Loriot, Y.; Stein, M. N.; Necchi, A.; Kojima, T.; Harrison, M. R.; more...
   Lancet Oncology (2021)

   Fulltext@MSK | Save
2. Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): Results from the IGCCCG Update Consortium

   Journal Article

   Gillessen, S.; Sauve, N.; Collette, L.; Daugaard, G.; de Wit, R.; Albany, C.; Tryakin, A.; Fizazi, K.; Stahl, O.; Gietema, J. A.; more...
   Journal of Clinical Oncology (2021)

   Fulltext@MSK | Save
3. Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer identifies targetable BRCA alterations and AR resistance mechanisms

   Journal Article

   Tukachinsky, H.; Madison, R. W.; Chung, J. H.; Gjoerup, O. V.; Severson, E. A.; Dennis, L.; Fendler, B. J.; Morley, S.; Zhong, L.; Graf, R. P.; more...
   Clinical Cancer Research (2021)

   Fulltext@MSK | Save